References
- Fridovich I. Biological effects of the superoxide radical. Arch. Biochem. Biophys. 1986; 247: 1–11
- Halliwell B., Gutteridge J. M. C. Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts. Arch. Biochem. Biophys. 1986; 246: 501–514
- Opie L. H. Reperfusion injury and its pharmacologic modification. Circulation 1989; 80: 1049–1062
- Kloner R. A., Przyklenk K., Whittaker P. Deleterious effect of oxygen radicals in ischemia/reperfusion: Resolved and unresolved issues. Circulation 1989; 80: 1115–1127
- Bolli R. Superoxide dismutase 10 years later: A drug in search of a use. J. Am. Coll. Cardiol. 1991; 18: 231–238
- Sjöquist P. O., Carlsson L., Jonason L., Marklund S. L., Abrahamsson T. Caridoprotective effects of recombinant human extracellular-superoxide dismutase type C in rat isolated heart to ischemia and reperfusion. J. Cardiouasc. Pharmacol. 1991; 17: 678–683
- Miura T., Ogawa S., Ooiwa H., Adachi T., Noto T., Shizukuda Y., Iimura O. Human superoxide dismutase failed to limit the size of myocardial infarct after 20-, 30- or 60-minutes ischemia and 72 hour reperfusion in the rabbit. Jpn Circ. J. 1989; 53: 786–794
- Galcia-Alves M., Kodowaki Y., Iwashita Y., Nishi K. Pretreatment with a single bolus injection of polyoxyethylene-modified superoxide dismutase prevents reperfusion induced arrhytmias in the anesthetize rat. Jpn J. Pharmacol. 1989; 51: 199–209
- Watanabe N., Inoue M., Morino Y. Inhibition of postischemic reperfusion arrhytmias by an SOD derivative that circulates bound to albumin with prolonged “in vivo” half-life. Biochem. Pharmacol. 1989; 38: 3477–3483
- Maksimenko A. V. Modified preparations of superoxide dismutase and catalase to protect cardiovascular system and lungs. Uspekhi souremennoi biologii 1993; 113: 351–365, [in Russian]
- Chi L., Tamura Y., Hoff P. T., Macha M., Gallagher K. P., Schork M. A., Lucchesi B. R. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: A demonstration of myocardial salvage. Circ. Res. 1989; 64: 665–675
- Hirota M., Inoue M., Ando Y., Morito Y. Inhibition of stress-induced gastric musocal injury by a long acting super-oxide dismutase that circulates bound to albumine. Arch. Biochem. Biophys. 1990; 280: 269–273
- Veronese F. M., Caliceti P., Pastorino A., Schiavon O., Sartore L., Banci L., Scolaro L. M. Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase. J. Contr. Rel. 1989; 10: 145–154
- Maksimenko A. V., Grigoryeva E. L., Morozkin A. D., Tischenko E. G., Minkovsky E. B., Torchilin V. P. The estimation of composition and structure of covalent complexes between superoxide dismutase and aldehyde dextran by analytical ultracentrifugation. Biokhimiya 1991; 56: 1330–1336, [in Russian]
- Maksimenko A. V., Bezrukavnikova L. M., Grigoryeva E. L., Yaglov V. V., Torchilin V. P. Effect of native and modified forms of superoxide dismutase and catalase on experimental silicosis in rats. Ann. N.Y. Acad. Sci. 1992; 672: 118–125
- Conforti A., Caliceti P., Sartore L., Schiavon O., Veronese F., Velo G. P. Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats. Pharmacol. Res. 1991; 23: 51–56
- Fraker P. J., Speck J. C., Jr. Protein and cell membrane iodinations with a sparingly soluble chloramine 1,3,4,6-tetrachloro-3a,4a-diphenylglycoacryl. Biochem. Biophys. Res. Commun. 1978; 80: 849–857
- Maksimenko A. V., Arkhipova O. G., Yaglov V. V., Torchilin V. P. Aldehyde dextran modified enzymes for medical application. “Interbiotech 87: Enzyme Technologies”, A. Blazej, J. Zemek. Elsevier, Amsterdam 1988; Vol. 4: 509–522
- Gutteridge J. M. C., Halliwell B. Reoxygenation injury and antioxidant protection: a tale of two paradoxes. Arch. Biochem. Biophys. 1990; 283: 223–226
- Roberts A. J., Cipriano P. L., Alonso D. R., Jacobstein J. G., Combes J. R., Gay W. A., Jr. Evaluation of methods for the quantification of experimental myocardial infarction. Circulation 1978; 57: 35–41
- Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ. Res. 1980; 47: 1–9
- Fujita T., Nishikawa M., Tamaki C., Takakura Y., Hashida M., Sezaki H. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono-and polysaccharide derivatives. J. Pharmacol. Exp. Ther. 1992; 263: 971–978
- Fujita T., Furutsu H., Nishikawa M., Takakura Y., Sezaki H., Hashida M. Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion. Biochem. Biophys. Res. Commun. 1992; 189: 191–196
- Igarashi R., Hoshino J., Takenaga M., Kawai S., Morizawa Y., Yasuda A., Otani M., Mizushima Y. Lecithinization of superoxide dismutase potentiates its protecting effect against Forssman antiserum-induced elevation in guinea pig airway resistance. J. Pharmacol. Exp. Ther. 1992; 262: 1214–1219
- Caliceti P., Schiavon O., Mocali A., Veronese F. M. Evaluation of monomethoxypolyethylene glycol derivatized superoxide dismutase in blood and evidence for its binding to blood cells. Il farmaco 1989; 44(7,8)711–720
- Beckman J. S., Minor R. L., Jr., White C. W., Repine J. E., Rosen G. M., Freeman B. A. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J. Biol. Chem. 1988; 263: 6884–6892